Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BI 706321 / Boehringer Ingelheim
NCT04978493 / 2020-004527-16: A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease	Active, not recruiting	2	49	Europe, US, RoW	BI 706321, ustekinumab, Placebo	Boehringer Ingelheim, Boehringer Ingelheim International GmbH	Crohn Disease	07/24	03/25
NCT05183360: A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated	Recruiting	1	60	Japan	BI 706321, Placebo	Boehringer Ingelheim	Healthy	10/25	10/25